Hybrid interferon/interferon tau proteins, compositions and methods of use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 19, 2007
Grant Date -
Jul 10, 2003
app pub date -
Aug 12, 2002
filing date -
Aug 12, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to hybrid interferon fusion proteins formed of an interferon-.alpha. protein where the C-terminal region of the interferon-.alpha. protein is replaced by a C-terminal region of interferon-.tau.. Also described are nucleic acid sequences encoding the interferon fusion proteins, expression vectors containing such sequences, and therapeutic applications of the interferon fusion proteins. The therapeutic applications include antiviral, anticellular proliferation, and anti-inflammatory applications. One advantage of the interferon fusion polypeptides of the present invention is that they have lower cytotoxic side effects when used to treat cells.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully